Skip to content

Rotational Stability After Nanoflex Collamer Toric Intraocular Lens Implantation in Astigmatic Patients

Rotational Stability After Nanoflex Collamer Toric Intraocular Lens Implantation in Astigmatic Patients Undergoing Cataract Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02412215
Acronym
T-IOL
Enrollment
60
Registered
2015-04-09
Start date
2015-03-31
Completion date
2017-09-30
Last updated
2015-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

This study aims to assess the rotational stability of the new collameric Nanoflex toric intraocular lens (T-IOL) by STAAR inserted in astigmatic patients after cataract surgery. The purpose of this study is also to determine whether the use of a toric intraocular lens (T-IOL) improves visual acuity.

Detailed description

A good rotational stability of toric intraocular lenses (T-IOL) allows an accurate refractive correction. However, many aspects -both pre-operative and post-operative- can interfere causing T-IOL rotation and misalignment. Complete preoperative ocular evaluation is performed including slit-lamp examination, uncorrected distance visual acuity (UDVA), best-corrected visual acuity (BCVA), Javal keratometry, corneal Scheimplug tomography (Pentacam), optical biometry (IOL Master), Goldman applanation tonometry and fundus evaluation through dilated pupils. The spherical IOL power is calculated considering the axial length obtained with optical biometry, the magnitude of astigmatism derived from Javal keratometry and the steepest axis obtained with corneal tomography. The power of the toric IOL is determined with the online Staar Toric IOL calculator. The reference landmarks are also marked preoperatively with a sterile methylene blue fine point pen. The marking is rechecked in the operating theatre with the electronic toric marker ASICO. Postoperative evaluation for IOL alignment and rotational stability is performed with slit-lamp photography on dilated pupils. Images are captured with Haag Streit slit lamp BQ 900 and are evaluated with the image-analysis software Protractor (Staar).

Interventions

PROCEDUREPhacoemulsification with toric Nanoflex IOL implantation

A self-sealing incision is made with a 2.2mm knife at 110°. Phacoemulsification is performed. The foldable nanoFlex toric IOL is injected in the capsular bag using the nanoPoint single-use injector system (STAAR) or 1620 sofTip Injector (ASICO). The IOL is rotated to align the cylinder axis with the steep corneal meridian using Z align function by Callisto Eye. Every movement of the IOL axis marks are noted.

DEVICENanoFlex toric Intraocular Lens

Sponsors

University of Turin, Italy
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients of 60 years of age ore more * Cataract * Corneal astigmatism of 1 diopter (D) or more

Exclusion criteria

* Primary or secondary pathological conditions of the cornea * Zonular fibres pathologies (phacodonesis, pseudoexfoliation syndrome) * Irregular astigmatism (corneal scar, keratoconus, pterygium) * Traumatic cataract * Previous ocular surgery * Complications during cataract surgery

Design outcomes

Primary

MeasureTime frameDescription
Change in rotational stability of the toric intraocular lens (T-IOL).Change of rotational stability at 1 day, 1 week, 1 month, 3 months, 6 months, 12 months and 18 months after surgery.The misalignment of the lens is defined as the difference (Δ) between the intended axis and the actual axis of the new collameric Nanoflex T-IOL by STAAR.

Secondary

MeasureTime frameDescription
Correction of the astigmatism.Change in visual acuity at 1 day, 1 week, 1 month, 3 months, 6 months, 12 months and 18 months after surgeryEffective correction evaluated through corrected distance visual acuity (CDVA) and uncorrected distance visual acuity (UDVA).

Countries

Italy

Contacts

Primary ContactAntonio M Fea, MD, PhD
antoniomfea@gmail.com+39 011 566 6039

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026